IU School of Medicine researchers have discovered life-changing research for one of the most aggressive and deadliest forms of breast cancer. What it means to survivors worried about the disease returning. Milan Radovich, co-leader of the Precision Health Triple Negative Breast Cancer program and Ginny Mason, a triple negative breast cancer survivor, discuss how the discovery is opening the door for a new study to uncover better treatments for patients.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}